Rocklatan

Alcon Laboratories, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 27, 2026
Approval ID: b1d71f41-be06-4a08-94d4-e352198f09c2
Products: 1 registered
Version: 15

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ROCKLATAN safely and effectively. See full prescribing information for ROCKLATAN. ROCKLATAN (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, for topical ophthalmic useInitial U.S. Approval: 2019

Quick Stats

Total Products1

Labelers2

Label Sections32

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.